An INtervention TO Improve MOBility of Older Hospitalized Patients

NCT ID: NCT05639231

Last Updated: 2025-08-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

383 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-12-15

Study Completion Date

2025-07-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Low mobility during an acute care hospitalization is very frequent, particularly among older patients, and associated with adverse outcomes, such as persistent functional decline, institutionalization and death. However, increasing hospital mobility remains challenging because of the multiple existing barriers.

The goal of this clinical trial is to test the effect of a multilevel intervention to increase hospital mobility, which addresses modifiable barriers and facilitators and does not require unavailable additional resources.

This study aims to answer whether this intervention can improve mobility and patient-relevant outcomes such as life-space mobility and functional status.

The multilevel intervention will target:

1. The patients, who will receive an information booklet, a customizable diary, an exercise booklet and an iPad with access to the videos of the exercise booklet.
2. The healthcare professionals (nursing staff and physicians) who will complete an e-learning, receive an oral presentation on the intervention, and receive a "mobility checklist" that reminds them of what they should assess daily regarding mobility.
3. The hospital environment, where posters will be hung in the wards, including walking itineraries, on topics of interest to older adults.

In a first phase, the intervention will be pilot-tested in one ward of each hospital. The intervention will then be adapted based on patient and healthcare professional feedback.

In a second phase, the intervention will be tested in a cluster randomized controlled trial, and compared to standard of care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hospital Mobility Mobility Limitation Life-Space Functional Status Hospital-Acquired Condition Muscle Atrophy or Weakness Sarcopenia Iatrogenic Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

In a first phase, the intervention will be pilot-tested in one ward of each hospital (no comparison group).

In a second phase, it will be tested in a parallel design (cluster randomized controlled trial).
Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors
Complete blinding is difficult due to the nature of the intervention and the design (cluster randomization).

To preserve blinding as much as possible, several strategies have been set.

At the cluster level (healthcare professional intervention): Since rotation across wards happens at the physician level, but is rare at the level of the nursing staff, the healthcare professional intervention targets mostly nurses. The healthcare professionals will be informed to avoid speaking about the intervention with colleagues of other wards.

At the patient level, differential information for candidates for the intervention or for the control group (the randomization group is known when first approaching candidates for participation because of the cluster design) will be provided. Candidates for the control group will receive only partial information without explaining the intervention. They will be informed orally at the end of the study about all aspects of the study.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

INTOMOB intervention

The intervention will be multilevel, targeting the patients, healthcare professionals (HCPs) and environment, as described under "Intervention description".

Group Type EXPERIMENTAL

INTOMOB intervention

Intervention Type BEHAVIORAL

The intervention will be multilevel, targeting the patients, healthcare professionals (HCPs) and environment:

PATIENTS:

* Information booklet on the importance/benefits of mobility, consequences of low mobility, how to be more active (with concrete information).
* Customizable diary to document mobility goals, results, difficulties and needs.
* Exercise booklet with explanations \& pictures of mobility exercises (supine, sitting, standing).
* iPad 10.2'' with videos of the exercises.

HCPs (physicians \& nursing staff):

* E-learning on the consequences of low mobility, barriers/facilitators to hospital mobility; recommendations, documentation, communication \& interdisciplinary collaboration regarding mobility; implementation.
* Oral presentation on the intervention.
* Checklist to remind HCPs to address mobility.

ENVIRONMENT:

* Posters in the wards about mobility and other topics of interest to older adults.
* Walking itineraries in the wards.

Control

Control procedure in the randomized trial:

* Patients will receive standard of care, including physiotherapy if prescribed by the hospital physician and usual mobility recommendations and support by the HCPs.
* HCPs will neither complete the e-learning, nor receive the checklist and the oral presentation.
* The environment will not be modified in regards to mobility. Already existing information on this topic (e.g., small posters hanging in patient rooms) will not be removed, since it corresponds to current standard of care in some hospitals.

In the pilot study, there will be no control procedure, since the objective is to assess experience and feasibility of the intervention, not its effects.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

INTOMOB intervention

The intervention will be multilevel, targeting the patients, healthcare professionals (HCPs) and environment:

PATIENTS:

* Information booklet on the importance/benefits of mobility, consequences of low mobility, how to be more active (with concrete information).
* Customizable diary to document mobility goals, results, difficulties and needs.
* Exercise booklet with explanations \& pictures of mobility exercises (supine, sitting, standing).
* iPad 10.2'' with videos of the exercises.

HCPs (physicians \& nursing staff):

* E-learning on the consequences of low mobility, barriers/facilitators to hospital mobility; recommendations, documentation, communication \& interdisciplinary collaboration regarding mobility; implementation.
* Oral presentation on the intervention.
* Checklist to remind HCPs to address mobility.

ENVIRONMENT:

* Posters in the wards about mobility and other topics of interest to older adults.
* Walking itineraries in the wards.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Admission to a general internal medicine (GIM) ward of a participating hospital
* Age ≥60 years
* Being ambulatory during the 2 weeks before admission (self-report)
* Living in the community (not in a nursing home or another institution) for at least the last 30 days prior to admission
* Ability to understand French or German
* Planned length of stay at least 3 days after enrollment
* For the pilot-study only: Possibility to start the study within 48 hours after admission to the GIM ward

Exclusion Criteria

* Medical contraindication to walk (e.g., wound not allowing loading weight)
* Wheelchair-bound
* End-of-life
* Severe psychiatric disorder (severe depression, schizophrenia, psychosis)
* Delirium (according to the Confusion Assessment Method \[CAM\])

Additional exclusion criterion for the pilot-study only:

\- Dementia (defined as Mini-Cog \<3)


* Cognitive impairment making impossible to use study material (=implement the intervention) and to understand and sign informed consent, based on clinical judgement, except if a proxy can be actively involved in the study and provides consent
* Severe visual impairment
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Swiss National Science Foundation

OTHER

Sponsor Role collaborator

Hôpital Fribourgeois

OTHER

Sponsor Role collaborator

Kantonsspital Baden

OTHER

Sponsor Role collaborator

Insel Gruppe AG, University Hospital Bern

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Carole E Aubert, MD, MSc

Role: PRINCIPAL_INVESTIGATOR

Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kantonsspital Baden

Baden, Canton of Aargau, Switzerland

Site Status

HFR-Fribourg - hôpital cantonal

Villars-sur-Glâne, Canton of Fribourg, Switzerland

Site Status

Spital Tiefenau, InselGruppe AG

Bern, , Switzerland

Site Status

Inselspital, Bern University Hospital, InselGruppe AG

Bern, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Mooser B, Bergsma D, Liechti FD, Baumgartner C, Gentizon J, Mean M, Wertli MM, Mancinetti M, Schmidt-Leuenberger J, Aubert CE. Impact of an INtervention to increase MOBility in older hospitalized medical patients (INTOMOB): Study protocol for a cluster randomized controlled trial. BMC Geriatr. 2023 Oct 31;23(1):705. doi: 10.1186/s12877-023-04285-3.

Reference Type DERIVED
PMID: 37907858 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-01568

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.